Skip to main content
. 2016 May 25;36:571–582. doi: 10.1007/s10875-016-0298-x

Table 1.

IGHy infusions during pivotal (excluding ramp-up) and extension studies by age group (<18, ≥18 years)

Pivotal study (excluding ramp-up) Extension study
Age groupa (years) Number of subjects treated Number of infusions administered Number of subjects treated Number of infusions administered
<18 22 310 15 364
≥18 59 819 48 1236
Total 81 1129 63 1600

aAge at screening in pivotal study